IPP Bureau
Alkem Laboratories posts Q4 FY23 consolidated PAT slides to Rs. 70.98 Cr
By IPP Bureau - May 20, 2023
The company has reported total income of Rs. 2971.27 crores during the period ended March 31, 2023
Strides Puducherry facility receives EIR from USFDA
By IPP Bureau - May 20, 2023
The USFDA had classified Strides Puducherry facility as OAI in May 2019 followed by issuing a warning letter to this site in July 2019.
Granules India received ANDA approval for Venlafaxine ER capsules
By IPP Bureau - May 20, 2023
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
Moderna presents Phase 1/2 of MRNA-3927at 2023 ASGCT Meeting
By IPP Bureau - May 20, 2023
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
Venus Remedies recognized for R&D excellence by DSIR
By IPP Bureau - May 19, 2023
Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions
Thermo Fisher Scientific expands ImmunoCAP test availability across U.S.
By IPP Bureau - May 19, 2023
Testing supporting allergy diagnosis now accessible to more people in more communities
Takeda to strengthen health system for rare diseases in India
By IPP Bureau - May 19, 2023
These initiatives aim to improve access to healthcare for rare disease patients
KIMS posts Q4FY23 consolidated PAT at Rs. 93.27 Cr
By IPP Bureau - May 19, 2023
The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023
Gland Pharma posts Q4 FY23 consolidated PAT at Rs. 78.68 Cr
By IPP Bureau - May 19, 2023
Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023
Philips’ image-guided navigation increases safety during coronary interventions
By IPP Bureau - May 17, 2023
Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
Pfizer Ltd posts Q4 FY23 PAT at Rs. 129.65 Cr
By IPP Bureau - May 17, 2023
The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023
Envision Scientific receives IGBC Gold Certification for India factory
By IPP Bureau - May 17, 2023
Concept Medical’s manufacturing arm has reduced its carbon footprint via in-house efficiency improvement programmes & green infrastructure
Emcure Pharmaceuticals to launch the750 mg injectable variant of ferric carboxymaltose
By IPP Bureau - May 17, 2023
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
Farxiga’s expanded approval highlights potential to differentiate in HF space, says GlobalData
By IPP Bureau - May 17, 2023
Farxiga is expected to have such a strong influence on the market due to the impressive results
Hikal announces USFDA audit with zero observations
By IPP Bureau - May 16, 2023
This latest audit re-emphasizes Hikal's commitment towards maintaining the best in class quality, compliance and regulatory standards across our manufacturing sites
